Plasma endothelin is increased in early essential hypertension |
| |
| Affiliation: | 1. Department of Medicine IV/Nephrology, University of Erlangen-Nürnberg, Nürnberg, Germany;1. Endocrinology-Hypertension Division (PR), Brigham and Women’s Hospital and Harvard Medical School (JS), Boston, Massachusetts, USA;2. Siebens-Drake/Robarts Research Institute, University of Western Ontario, London, Ontario, Canada;3. Cardiovascular Research Institute (BW), University of Leicester, Leicester, United Kingdom;4. Nephrology Division (AR), UNIFESP-EPM, São Paulo, Brazil;5. Health Center (IS), Keio University, Tokyo, Japan;6. University of Texas Medical School (CB), Houston, Texas, USA;7. Merck & Co. Inc. (AMGB), Whitehouse Station, New Jersey, USA;1. Medical Research Service, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA;2. Departments of Medicine and Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin, USA;1. Human Performance Laboratory, Department of Exercise and Sport Science, East Carolina University, Greenville, North Carolina, USA;2. Department of Physiology, East Carolina University, Greenville, North Carolina, USA;1. Department of Physiology and Biophysics, University of Louisville, School of Medicine, Louisville, Kentucky, USA;1. Department of Cardiology (DAD, MLDB, TLDB, NVDV, DLC) and Angiology, Ghent University Hospital, Ghent, Belgium;2. Cardiovascular Division (JNC), Department of Medicine, University of Minnesota, Medical School, Minneapolis, Minnesota, USA |
| |
| Abstract: | Local vascular generation of endothelin-1 (ET-1) may contribute to elevated peripheral resistance in hypertension. We tested the hypothesis that immunoreactive ET production in the forearm circulation is increased in early essential hypertensive subjects. Ten young, previously untreated male patients with mild essential hypertension and no signs of target organ damage were compared with matched normotensive subjects in an outpatient setting. Arterial and venous samples were obtained from indwelling catheters in the brachial artery and the medial cubital vein, respectively. Samples were collected at baseline and after induction of endothelium-dependent (acetylcholine) vasodilation. Immunoreactive ET (ET) was measured after column extraction by a sensitive radioimmunoassay employing a C-terminal ET-1 antibody with negligible cross-reaction to big-ET. Individual recovery rates were determined for each sample.Basal ET was significantly higher in hypertensive than in normotensive subjects, both in venous and arterial samples (P < .01). This difference was also present after correction for recovery (P < .01). There was no significant difference between venous and arterial ET concentrations. Local vasodilation did not change arterial or venous ET levels. In conclusion, plasma ET is increased in young, untreated, essential hypertensive subjects with no signs of target organ damage. The increased circulating immunoreactive ET may point to a role for the peptide early in the development of high blood pressure. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
